TheWell Bioscience Launches RocketCell™ AOF B27-Like, N2-Like, and N2B27-Like Supplements, Advancing NAMs and Future GMP Development
Detailed summary
SOUTH BRUNSWICK TOWNSHIP, N.J., Nov. 12, 2026 /PRNewswire/ -- TheWell Bioscience, a developer of an integrated animal origin-free 3D cell culture platform, announced the launch of…
SOUTH BRUNSWICK TOWNSHIP, N.J., Nov. 12, 2026 /PRNewswire/ -- TheWell Bioscience, a developer of an integrated animal origin-free 3D cell culture platform, announced the launch of RocketCell™ S1, S2, and S3 Supplements, AOF, a new portfolio of animal origin-free supplements designed to support reproducible and scalable stem cell, neural, organoid, and other advanced cell culture applications.
The portfolio includes RocketCell™ S1 Supplement (B27-like), RocketCell™ S2 Supplement (N2-like), and RocketCell™ S3 Supplement (N2B27-like premix). The launch expands the company's end-to-end animal origin-free (AOF) portfolio, giving researchers additional tools to build human-relevant cell culture platforms for New Approach Methodologies (NAMs) and other advanced research applications.
Explore RocketCell™ Animal Origin-Free B27-Like, N2-Like, and N2B27-Like Supplements.
"Our goal is to help human-relevant platforms move beyond the research lab and ultimately toward GMP production and clinical translation," said John Huang, Ph.D., CEO of TheWell Bioscience. "RocketCell™ S1, S2, and S3 strengthen the animal origin-free tools available to researchers today. By synthetic hydrogels, integrating media, recombinant growth factors, cultureware, and workflow reagents, our end-to-end AOF platform supports the development of more standardized and reproducible human-relevant models for NAMs. This integrated approach also supports our long-term strategy to develop GMP-grade solutions for future biomanufacturing and clinical applications."
Reducing animal-origin components helps researchers better control culture inputs and minimize biological variability. RocketCell™ S1, S2, and S3 provide animal origin-free alternatives to conventional N2- and B27-type supplements for advanced cell culture workflows.
The supplements complement TheWell Bioscience's expanding AOF ecosystem, including RocketCell™ media, VitroGel® synthetic hydrogels, CytoGrow™ recombinant growth factors, VitroPrime™…
RocketCell™…
Opening of the article, excerpted from PR Newswire. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)
